Add to ORKGIntroduction: Despite high rates of successful treatment TB incidence in South Africa remains high, suggesting ongoing transmission and a large reservoir of latently infected persons. Isoniazid preventive therapy (IPT) is recommended as preventive therapy in HIV-infected persons. However, implementation has been slow, impeded by barriers and challenges including the fear of non-adherence. Objective and Methods: The aim was to evaluate predictors of IPT non-completion. One hundred and sixty fou
SETTINGUrban clinical research site in Durban, South AfricaOBJECTIVETo describe the outcomes associa...
Background: Isoniazid preventive therapy (IPT) has been shown to reduce the risk of tuberculosis (TB...
Background: Proper adherence to isoniazid preventive therapy (IPT) may depend upon the results of tu...
Despite high rates of successful treatment TB incidence in South Africa remains high, suggesting ong...
Despite high rates of successful treatment TB incidence in South Africa remains high, suggesting ong...
Introduction: Despite high rates of successful treatment TB incidence in South Africa remains high, ...
Background. The researchers identified infection with HIV as the strongest risk factor in the reacti...
Background. The researchers identified infection with HIV as the strongest risk factor in the reacti...
BackgroundIsoniazid preventive therapy (IPT) is given to HIV patients to reduce the risk of active t...
Setting: Seven pilot sites in Zimbabwe implementing 6 months of isoniazid preventive therapy (IPT) f...
SettingFour primary health care clinics providing tuberculosis (TB) and Human Immunodeficiency Virus...
SETTING: To reduce the risk of tuberculosis (TB) among individuals with human immunodeficiency virus...
Trials of isoniazid preventive therapy (IPT) for people living with HIV in southern Africa have show...
Background: Tuberculosis (TB) is the leading cause of death in persons living with HIV (PLHIV). PLHI...
BACKGROUND: In HIV-uninfected individuals, isoniazid preventive therapy (IPT) has been associated wi...
SETTINGUrban clinical research site in Durban, South AfricaOBJECTIVETo describe the outcomes associa...
Background: Isoniazid preventive therapy (IPT) has been shown to reduce the risk of tuberculosis (TB...
Background: Proper adherence to isoniazid preventive therapy (IPT) may depend upon the results of tu...
Despite high rates of successful treatment TB incidence in South Africa remains high, suggesting ong...
Despite high rates of successful treatment TB incidence in South Africa remains high, suggesting ong...
Introduction: Despite high rates of successful treatment TB incidence in South Africa remains high, ...
Background. The researchers identified infection with HIV as the strongest risk factor in the reacti...
Background. The researchers identified infection with HIV as the strongest risk factor in the reacti...
BackgroundIsoniazid preventive therapy (IPT) is given to HIV patients to reduce the risk of active t...
Setting: Seven pilot sites in Zimbabwe implementing 6 months of isoniazid preventive therapy (IPT) f...
SettingFour primary health care clinics providing tuberculosis (TB) and Human Immunodeficiency Virus...
SETTING: To reduce the risk of tuberculosis (TB) among individuals with human immunodeficiency virus...
Trials of isoniazid preventive therapy (IPT) for people living with HIV in southern Africa have show...
Background: Tuberculosis (TB) is the leading cause of death in persons living with HIV (PLHIV). PLHI...
BACKGROUND: In HIV-uninfected individuals, isoniazid preventive therapy (IPT) has been associated wi...
SETTINGUrban clinical research site in Durban, South AfricaOBJECTIVETo describe the outcomes associa...
Background: Isoniazid preventive therapy (IPT) has been shown to reduce the risk of tuberculosis (TB...
Background: Proper adherence to isoniazid preventive therapy (IPT) may depend upon the results of tu...